Efficacy of Nonsteroidal Anti-inflammatory Drugs in Treatment of Moderate and Severe Dry Eye Disease
NCT01562795 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 48
Last updated 2014-01-03
Summary
This clinical trial is to investigate whether nonsteroid anti-inflammatory drops have therapeutic effect on moderate to severe dry eye patients.And compare the efficacy of the two nonsteroid anti-inflammatory drops with topical corticosteroids.
Conditions
- Moderate to Severe Dry Eye Syndrome
Interventions
- DRUG
-
nonsteroid anti-inflammatory drops
nonsteroid anti-inflammatory drops plus artificial tear substitute
- DRUG
-
nonsteroid anti-inflammatory drops
nonsteroid anti-inflammatory drops plus artificial tear substitute
- DRUG
-
corticosteroids plus artificial tear substitute
- DRUG
-
artificial tear substitute
artificial tear substitute alone
Sponsors & Collaborators
-
Wenzhou Medical University
lead OTHER
Principal Investigators
-
Wei Chen, MD,PhD · Eye Hospital, Wenzhou Medical College, China
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-03-31
- Primary Completion
- 2012-06-30
- Completion
- 2012-07-31
Countries
- China
Study Locations
More Related Trials
-
Dry Eye Under China's Dynamic COVID-zero Strategy
NCT05476068 ·Status: COMPLETED
-
Efficacy and Safety of SJP-0132 Eye Drops in Chinese Patients With Dry Eye Disease
NCT06717152 ·Status: COMPLETED ·Phase: PHASE3
-
Phase II Study of DA-6034 Eye Drops in Dry Eye Syndrome
NCT01670357 ·Status: COMPLETED ·Phase: PHASE2
-
A Parallel Group Phase II Study of KCT-0809 in Patients With Dry Eye Syndromes
NCT01692145 ·Status: COMPLETED ·Phase: PHASE2
-
A Study Evaluating the Efficacy and Safety on Moderate to Severe Dry Eye
NCT04092907 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Acceptability of Two Lubricant Eye Drops
NCT00756678 ·Status: COMPLETED ·Phase: PHASE4
-
A Phase II Study of KCT-0809 in Patients With Dry Eye Syndrome
NCT01427816 ·Status: COMPLETED ·Phase: PHASE2
-
HU007 Eye Drops in Patients With Dry Eye Syndrome
NCT04384991 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Confirm the Efficacy and Safety of K-161 Ophthalmic Solution for Treatment of Moderate to Severe Dry Eye Disease
NCT05403827 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of BUFY02 Versus TRB02 in the Treatment of Dry Eye Disease
NCT05865457 ·Status: RECRUITING ·Phase: NA
-
Safety and Efficacy of Two Artificial Tears in Dry Eye Subjects
NCT01010282 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of BUFY01 Versus SVS20 in the Treatment of Dry Eye Disease
NCT05865379 ·Status: RECRUITING ·Phase: NA
-
The Germinal Peptide Eye Drops in Healthy Volunteers in a Clinical Study
NCT03967548 ·Status: COMPLETED ·Phase: PHASE1
-
A Randomized Study of Smile Exercise for Dry Eye
NCT04421300 ·Status: COMPLETED ·Phase: NA
-
Therapeutic Effect of Stem Cell Eye Drops on Dry Eye Disease
NCT05784519 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Phase I Study to Evaluate the Tolerability of Eye Drop DA-6034 in Healthy Volunteers
NCT01162954 ·Status: COMPLETED ·Phase: PHASE1
-
Study of INS365 Ophthalmic Solution in Subjects With Dry Eye Disease
NCT00404131 ·Status: COMPLETED ·Phase: PHASE3
-
Artificial Tears Study in Mild to Moderate Dry Eye Patients
NCT00607776 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Study to Investigate the Efficacy and Safety of Orally Administered SA001 in Patients With Dry Eye Syndrome.
NCT03723798 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of SHR8058 on Signs and Symptoms of Dry Eye Disease Associated With Meibomian Gland Dysfunction
NCT05515471 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Tolerability of Artificial Tears in Dry Eye Subjects
NCT00932477 ·Status: COMPLETED ·Phase: NA
-
Late Phase II Confirmatory Study of DE-089 Ophthalmic Solution in Patients With Dry Eye
NCT01189032 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Safety, Tolerability, and Efficacy of A197 in Subjects With Dry Eye Disease
NCT05238597 ·Status: COMPLETED ·Phase: PHASE2
-
Microvascular and Inflammatory Responses of 0.05 Cyclosporine Eye Drop (II) in Treatment of Dry Eye
NCT05131152 ·Status: UNKNOWN ·Phase: NA
-
Povidone-iodine 2% Eye Drop Versus Artificial Tear Drop for Treatment of Adenoviral Keratoconjunctivitis
NCT04041856 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2